Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers

Summary

This is a double-blind, randomized, placebo-controlled, 4-period, cross-over clinical trial. The study is designed to evaluate the safety and local tolerability of DA-6034 upon single and repeated-dose topical application to the both eyes in healthy volunteers.

Timeline

Start

2008-09

Primary completion

2009-03

Completion

2009-03

Drugs

Indications